Sou Hu Cai Jing·2026-01-28 01:47Company Overview - Gan Zhicao has submitted a listing application to the Hong Kong Stock Exchange, with CITIC Securities International and Shenwan Hongyuan Hong Kong acting as joint sponsors [1] - The company is a digital-driven online comprehensive service provider in traditional Chinese medicine (TCM), covering online TCM diagnosis, TCM medical institution services, and TCM health products [1] - Gan Zhicao holds a leading position in the market, with a 4.9% market share among the top five online TCM service providers in China, and ranks first in the online TCM diagnosis service market with a 16.7% market share [1] Core Products and Services - The core products include the online diagnosis platform "Gan Cao Doctor," a SaaS and supply chain system "Gan Cao Cloud Manager" designed for TCM medical institutions, and the AI-assisted intelligent diagnosis program "Xuanqi Wendu," developed in collaboration with Zhejiang Chinese Medical University [1] - The company operates a smart shared pharmacy network consisting of 7 self-operated, 7 joint venture, and 52 outsourced pharmacies responsible for the preparation, processing, distribution, and delivery of traditional Chinese medicine [1] - Gan Zhicao has launched the "Gan Cao Life | Gan Zhi Yi" brand, which sells TCM health products [1] Industry Insights - The Chinese TCM industry is experiencing continuous growth, with the market size expected to reach 22,615 billion RMB by 2029 [2]